1. Home
  2. BYND vs YMAB Comparison

BYND vs YMAB Comparison

Compare BYND & YMAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYND
  • YMAB
  • Stock Information
  • Founded
  • BYND 2009
  • YMAB 2015
  • Country
  • BYND United States
  • YMAB United States
  • Employees
  • BYND N/A
  • YMAB N/A
  • Industry
  • BYND Packaged Foods
  • YMAB Biotechnology: Pharmaceutical Preparations
  • Sector
  • BYND Consumer Staples
  • YMAB Health Care
  • Exchange
  • BYND Nasdaq
  • YMAB Nasdaq
  • Market Cap
  • BYND 293.8M
  • YMAB 270.5M
  • IPO Year
  • BYND 2019
  • YMAB 2018
  • Fundamental
  • Price
  • BYND $3.53
  • YMAB $4.78
  • Analyst Decision
  • BYND Sell
  • YMAB Buy
  • Analyst Count
  • BYND 6
  • YMAB 11
  • Target Price
  • BYND $4.92
  • YMAB $19.64
  • AVG Volume (30 Days)
  • BYND 4.2M
  • YMAB 408.2K
  • Earning Date
  • BYND 05-07-2025
  • YMAB 03-04-2025
  • Dividend Yield
  • BYND N/A
  • YMAB N/A
  • EPS Growth
  • BYND N/A
  • YMAB N/A
  • EPS
  • BYND N/A
  • YMAB N/A
  • Revenue
  • BYND $326,452,000.00
  • YMAB $87,685,000.00
  • Revenue This Year
  • BYND $3.65
  • YMAB $20.07
  • Revenue Next Year
  • BYND $1.84
  • YMAB $8.76
  • P/E Ratio
  • BYND N/A
  • YMAB N/A
  • Revenue Growth
  • BYND N/A
  • YMAB 3.38
  • 52 Week Low
  • BYND $2.86
  • YMAB $4.25
  • 52 Week High
  • BYND $10.31
  • YMAB $17.78
  • Technical
  • Relative Strength Index (RSI)
  • BYND 45.48
  • YMAB 31.48
  • Support Level
  • BYND $3.03
  • YMAB $4.62
  • Resistance Level
  • BYND $3.50
  • YMAB $5.03
  • Average True Range (ATR)
  • BYND 0.27
  • YMAB 0.37
  • MACD
  • BYND 0.01
  • YMAB -0.01
  • Stochastic Oscillator
  • BYND 50.24
  • YMAB 27.45

About BYND Beyond Meat Inc.

Beyond Meat Inc is a provider of plant-based meat company offering a portfolio of revolutionary plant-based meats. It builds meat directly from plants, an innovation that enables consumers to experience the taste, texture and other sensory attributes of popular animal-based meat products while enjoying the nutritional and environmental benefits of eating plant-based meat product It has products such as burgers, sausage, ground beef, jerky, meatballs and chicken. The company generates revenue from sales of its products to the customers across mainstream grocery, mass merchandiser, club store, convenience store and natural retailer channels, and various food-away-from-home channels, including restaurants, foodservice outlets and schools, mainly in the United States.

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

Share on Social Networks: